Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Salivary Lactate Dehydrogenase (LDH)- A Novel Technique in Oral Cancer Detection and Diagnosis.

Lokesh K, Kannabiran J, Rao MD.

J Clin Diagn Res. 2016 Feb;10(2):ZC34-7. doi: 10.7860/JCDR/2016/16243.7223. Epub 2016 Feb 1.

2.

Interleukin-8: A potent promoter of angiogenesis in gastric cancer.

Shi J, Wei PK.

Oncol Lett. 2016 Feb;11(2):1043-1050. Epub 2015 Dec 15.

3.

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

Molina-Pinelo S, Gutiérrez G, Pastor MD, Hergueta M, Moreno-Bueno G, García-Carbonero R, Nogal A, Suárez R, Salinas A, Pozo-Rodríguez F, Lopez-Rios F, Agulló-Ortuño MT, Ferrer I, Perpiñá A, Palacios J, Carnero A, Paz-Ares L.

PLoS One. 2014 Mar 13;9(3):e90524. doi: 10.1371/journal.pone.0090524. eCollection 2014.

4.

Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model.

Wurz GT, Gutierrez AM, Greenberg BE, Vang DP, Griffey SM, Kao CJ, Wolf M, DeGregorio MW.

J Transl Med. 2013 Mar 13;11:64. doi: 10.1186/1479-5876-11-64.

5.

RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.

Yamazoe S, Tanaka H, Sawada T, Amano R, Yamada N, Ohira M, Hirakawa K.

J Exp Clin Cancer Res. 2010 May 23;29:53. doi: 10.1186/1756-9966-29-53.

6.

Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.

VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW Jr, Kittles RA, Kidd LC.

Prostate. 2010 Mar 1;70(4):341-52. doi: 10.1002/pros.21067.

7.

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD, Pollack JR.

Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6. Epub 2004 Jan 7.

8.

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.

Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL; Tumour and Angiogenesis Research Group..

Br J Cancer. 2003 Sep 1;89(5):877-85.

9.

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis.

Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP.

Br J Cancer. 2002 Sep 23;87(7):694-701.

10.

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL.

Br J Cancer. 2001 Sep 14;85(6):881-90.

Supplemental Content

Support Center